207 related articles for article (PubMed ID: 18664951)
21. Cost-effectiveness of staff and workload profiles in retaining patients on antiretroviral therapy in KwaZulu-Natal, South Africa.
Vella V; Govender T; Dlamini SS; Moodley I; David V; Taylor M; Jinabhai CC
AIDS Care; 2011 Sep; 23(9):1146-53. PubMed ID: 21562993
[TBL] [Abstract][Full Text] [Related]
22. Cost of medical care for HIV-infected patients within a regional population from 1997 to 2006.
Krentz HB; Gill MJ
HIV Med; 2008 Oct; 9(9):721-30. PubMed ID: 18643856
[TBL] [Abstract][Full Text] [Related]
23. Antiretroviral therapy and HIV prevention in India: modeling costs and consequences of policy options.
Over M; Marseille E; Sudhakar K; Gold J; Gupta I; Indrayan A; Hira S; Nagelkerke N; Rao AS; Heywood P
Sex Transm Dis; 2006 Oct; 33(10 Suppl):S145-52. PubMed ID: 17003679
[TBL] [Abstract][Full Text] [Related]
24. Combining evidence for access to and benefits from antiretroviral treatment to inform planning.
; Marlink R; Forsythe S; Bertozzi SM; Muirhead D; Holmes M; Sturchio J
AIDS; 2008 Jul; 22 Suppl 1():S121-2. PubMed ID: 18664943
[No Abstract] [Full Text] [Related]
25. The real challenges for scaling up ART in sub-Saharan Africa.
Van Damme W; Kober K; Laga M
AIDS; 2006 Mar; 20(5):653-6. PubMed ID: 16514294
[No Abstract] [Full Text] [Related]
26. The obligation to provide antiretroviral treatment in HIV prevention trials.
Lo B; Padian N; Barnes M
AIDS; 2007 Jun; 21(10):1229-31. PubMed ID: 17545698
[TBL] [Abstract][Full Text] [Related]
27. The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
Dutta A; Barker C; Kallarakal A
PLoS Med; 2015 Nov; 12(11):e1001907; discussion e1001907. PubMed ID: 26599990
[TBL] [Abstract][Full Text] [Related]
28. Antiretroviral treatment and the health workforce in South Africa: how have ART workers been affected by scaling up?
Tobi P; George G; Schmidt E; Renton A
Trop Med Int Health; 2008 Dec; 13(12):1452-8. PubMed ID: 18983271
[TBL] [Abstract][Full Text] [Related]
29. Assessment of a national monitoring and evaluation system for rapid expansion of antiretroviral treatment in Malawi.
Lowrance D; Filler S; Makombe S; Harries A; Aberle-Grasse J; Hochgesang M; Libamba E
Trop Med Int Health; 2007 Mar; 12(3):377-81. PubMed ID: 17313509
[TBL] [Abstract][Full Text] [Related]
30. Impact of baseline health and community support on antiretroviral treatment outcomes in HIV patients in South Africa.
Wouters E; Van Damme W; van Rensburg D; Meulemans H
AIDS; 2008 Nov; 22(18):2545-8. PubMed ID: 19005281
[TBL] [Abstract][Full Text] [Related]
31. Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa.
Harries AD; Zachariah R; Lawn SD
Int J Tuberc Lung Dis; 2009 Jan; 13(1):6-16. PubMed ID: 19105873
[TBL] [Abstract][Full Text] [Related]
32. Examining the production costs of antiretroviral drugs.
Pinheiro E; Vasan A; Kim JY; Lee E; Guimier JM; Perriens J
AIDS; 2006 Aug; 20(13):1745-52. PubMed ID: 16931939
[TBL] [Abstract][Full Text] [Related]
33. Examining catastrophic costs and benefit incidence of subsidized antiretroviral treatment (ART) programme in south-east Nigeria.
Onwujekwe O; Dike N; Chukwuka C; Uzochukwu B; Onyedum C; Onoka C; Ichoku H
Health Policy; 2009 May; 90(2-3):223-9. PubMed ID: 19036466
[TBL] [Abstract][Full Text] [Related]
34. [Costs and adherence to antiretroviral treatment].
Ventura-Cerdá JM; Ayago-Flores D; Vicente-Escrig E; Mollá-Cantavella S; Alós-Almiñana M
Farm Hosp; 2010; 34(6):284-92. PubMed ID: 20692861
[TBL] [Abstract][Full Text] [Related]
35. The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa.
Long L; Fox M; Sanne I; Rosen S
AIDS; 2010 Mar; 24(6):915-9. PubMed ID: 20042849
[TBL] [Abstract][Full Text] [Related]
36. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
[TBL] [Abstract][Full Text] [Related]
37. Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up.
Calmy A; Klement E; Teck R; Berman D; Pécoul B; Ferradini L
AIDS; 2004 Dec; 18(18):2353-60. PubMed ID: 15622311
[No Abstract] [Full Text] [Related]
38. The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa--a primary data analysis.
Cleary SM; McIntyre D; Boulle AM
Cost Eff Resour Alloc; 2006 Dec; 4():20. PubMed ID: 17147833
[TBL] [Abstract][Full Text] [Related]
39. Why and how to monitor the cost and evaluate the cost-effectiveness of HIV services in countries.
Beck EJ; Santas XM; Delay PR
AIDS; 2008 Jul; 22 Suppl 1():S75-85. PubMed ID: 18664958
[TBL] [Abstract][Full Text] [Related]
40. The public health approach to antiretroviral treatment (ART) service scale-up in Ethiopia: the first two years of free ART, 2005-2007.
Assefa Y; Kloos H
Ethiop Med J; 2008 Oct; 46(4):401-6. PubMed ID: 19271406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
